Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
5 Years to 25 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
CP patients with therapy-resistent spasticity
Patients with sufficient body weight in relation to the volume
Oral medication has failed: insufficient effect or too many side-effects
The patient and family understand the objectives of the treatment and accept those objectives